Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity
- 8 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 59 (6), 875-884
- https://doi.org/10.1007/s00262-009-0813-5
Abstract
We reported that murine tumor lysate-pulsed dendritic cells (TP-DC) could elicit tumor-specific CD4+ and CD8+ T cells in vitro and in vivo. In some limited cases, TP-DC treatments in vivo could also result in regression of established subcutaneous tumors and lung metastases. By gene array analysis, we reported a high level of expression of a novel member of the cell surface class A scavenger receptor family, MARCO, by murine TP-DC compared to unpulsed DC. MARCO is thought to play an important role in the immune response by mediating binding and phagocytosis, but also in the formation of lamellipodia-like structures and dendritic processes. We have now examined the biologic and therapeutic implications of MARCO expressed by TP-DC. In vitro exposure of TP-DC to a monoclonal anti-MARCO antibody resulted in a morphologic change of rounding with disappearance of dendritic-like processes. TP-DC remained viable after anti-MARCO antibody treatment; had little, if any, change in production of IL-10, IL-12p70 and TNF-alpha; but demonstrated enhanced migratory capacity in a microchemotaxis assay. The use of a selective inhibitor showed MARCO expression to be linked to the p38 mitogen-activated protein kinase (MAPK) pathway. In vivo, anti-MARCO antibody treated TP-DC showed better trafficking from the skin injection site to lymph node, enhanced generation of tumor-reactive IFN-gamma producing T cells, and improved therapeutic efficacy against B16 melanoma. These results, coupled with our finding that human monocyte-derived DC also express MARCO, could have important implications to human clinical DC vaccine trials.Keywords
This publication has 41 references indexed in Scilit:
- Maximizing dendritic cell migration in cancer immunotherapyExpert Opinion on Biological Therapy, 2008
- Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagementJournal of Dermatological Science, 2006
- Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic processInternational Journal of Experimental Pathology, 2004
- Murine dendritic cell development: Difficulties associated with subset analysisImmunology & Cell Biology, 2003
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Morphological Interactions of Interdigitating Dendritic Cells with B and T Cells in Human Mesenteric Lymph NodesThe American Journal of Pathology, 2001
- Dendritic Cell Survival and Maturation Are Regulated by Different Signaling PathwaysThe Journal of Experimental Medicine, 1998
- A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infectionNature, 1997
- Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophagesCell, 1995
- Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.The Journal of Experimental Medicine, 1987